Midgard Science

ImpriMed

Palo Alto, CA, United States imprimedicine.com From their website, Nov 2026

Work here? Claim this listing

About

ImpriMed provides AI-driven precision medicine services for veterinary oncology, human blood-cancer oncology, and pharmaceutical CRO clients. It works with veterinarians, physicians, oncologists, and pharmaceutical companies from Palo Alto, California.

Services

  • Veterinary precision medicine

    Provides personalized drug response predictions for canine and feline blood cancers.

  • Human precision medicine

    Predicts patient-specific drug responses using precision analytics for human oncology.

  • Ex vivo CRO services for pharma

    Uses live-cell-based analytics to support oncology drug development programs.

  • Combination optimization

    Ranks synergistic regimens in primary patient cells.

  • Drug-resistance profiling

    Evaluates activity where standard of care fails.

  • Biomarker validation

    Tests candidate markers for use in enrichment rules.

  • Translational immunotherapy

    Measures antigen, engagement, and killing in patient cells.

  • Flow cytometry panels

    Offers add-on flow cytometry panel analysis.

8 more services
  • Sequencing and transcriptomics
  • Cryopreservation and biobanking
  • Personalized prediction profile
  • Flow cytometry and CHOP predictions
  • Immunoprofile flow cytometry
  • PARR
  • Multidrug sensitivity genotyping (MDR1)
  • Cytology
Turnaround
Within 1-2 business days
What to send
  • Single primary patient sample
  • Primary patient cells

Capabilities

Assays and studies
  • Flow cytometry
  • NGS
  • Bispecifics
  • ADCs
  • Peptides
  • Oligonucleotides
14 more
  • Small molecules
  • Ex vivo drug sensitivity
  • Dose-response
  • AUC
  • E max
  • Drug combination synergy
  • Synergy scoring
  • Antagonism scoring
  • Multiparameter flow cytometry
  • Drug effect
  • Antigen density
  • Target engagement
  • Malignant vs. normal selectivity
  • ML-integrated analysis
Scale and capacity
  • Single primary patient sample
  • 20+ drug standard panel
Therapeutic areas
  • Oncology
  • Veterinary oncology
  • Blood cancers
  • Acute myeloid leukemia
  • Acute lymphoblastic leukemia
  • Non-Hodgkin lymphoma
3 more
  • Multiple myeloma
  • Myelodysplastic syndromes
  • Comparative oncology

Instruments and platforms

  • Flow cytometry

Modalities and species

Modalities
  • Small molecule
  • Bispecific
  • ADC
  • Peptide
  • Oligonucleotide
Species and models
  • Canine
  • Feline
  • Primary patient cells
  • Primary human cells
  • Blood-cancer patient cells
  • Blast compartments
3 more
  • Stem-cell compartments
  • Differentiated compartments
  • Immune compartments

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO/IEC 17025Self-reported

  • CLIASelf-reported

Details

Type
CRO
Quality
FDA Modernization Act 2.0 (2022) (human-derived, cell-based functional data)
Based in
Palo Alto, CA, United States

Public records

Biocom California CRO directory
Biomarker Discovery & Validation, Ex vivo drug sensitivity testing, Patient Stratification, Translational Oncology CRO source

Similar labs